HROW: harrowinc.com Cash per Single Share

Harrow Corp - graphic logo of issuer HROW

Harrow, Inc. is developing the largest direct-sales network of ophthalmology brands in the US, acquired from pharmaceutical behemoths. The cash per share visualizes this growth, where the parameter value reaches 2.02. This results from the consolidation of innovative products for surgeons and exceptional pricing power over scarce drugs, which guarantees a steady flow of liquidity.

Harrow Health (HROW) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Harrow Inc (HROW)

- market price and analyst price targets:
- cash availability and cash flow indicators:
General company analysis:Harrow, Inc.
Product sample of Harrow

Harrow, Inc. (HROW) investments in a high-paid staff of ophthalmologists require strict liquidity control, which this metric reflects through the ratio of net cash to the number of shares. By analyzing the change in cash per share, an investor assesses the balance between capital accumulation and its efficient utilization, where excess funds reduce profitability while a deficit creates financial risks.